Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia
- PMID: 15226218
- DOI: 10.1161/01.CIR.0000135472.28234.CC
Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia
Abstract
Background: Tachycardia-induced cardiomyopathy is a reversible cause of heart failure. We hypothesized that although left ventricular ejection fraction measurements normalize after heart rate or rhythm control in patients with tachycardia-induced cardiomyopathy, recurrent tachycardia may have abrupt and deleterious consequences.
Methods and results: Patients with tachycardia-induced cardiomyopathy that developed over years were evaluated and treated. Tachycardia episodes and outcomes were assessed. Twenty-four patients were identified. All had NYHA functional class III heart failure or greater on presentation. One third were heart transplant candidates. There were 17 men and 7 women with a mean age of 46+/-16 years and mean left ventricular ejection fraction of 0.26+/-0.09 at the index visit. The cause was atrial fibrillation (n=13), atrial flutter (n=4), atrial tachycardia (n=3), idiopathic ventricular tachycardia (n=1), permanent junctional reciprocating tachycardia (n=2), and bigeminal ventricular premature contractions (n=1). Within 6 months of rate control or correction of the rhythm, left ventricular ejection fraction improved or normalized and symptoms abated in all. Five patients had tachycardia recur. In these patients, left ventricular ejection fraction dropped precipitously and heart failure ensued within 6 months, even though the initial impairment took years. Rate control eliminated heart failure and improved or normalized ejection fraction in 6 months. Three of 24 patients died suddenly and unexpectedly.
Conclusions: Tachycardia-induced cardiomyopathy develops slowly and appears reversible by left ventricular ejection fraction improvement, but recurrent tachycardia causes rapid decline in left ventricular function and development of heart failure. Sudden death is possible.
Similar articles
-
Arrhythmias and sudden death after dynamic cardiomyoplasty.Circulation. 1994 Nov;90(5 Pt 2):II107-11. Circulation. 1994. PMID: 7955235
-
Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the Cox-maze procedure significantly improves systolic function and functional status.Ann Thorac Surg. 2006 Aug;82(2):494-500; discussion 500-1. doi: 10.1016/j.athoracsur.2006.03.075. Ann Thorac Surg. 2006. PMID: 16863752
-
[Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].Arch Mal Coeur Vaiss. 1996 Apr;89(4):435-44. Arch Mal Coeur Vaiss. 1996. PMID: 8763003 Review. French.
-
Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.Chin Med J (Engl). 2009 Apr 5;122(7):802-6. Chin Med J (Engl). 2009. PMID: 19493393 Clinical Trial.
-
[Tachycardia-induced cardiomyopathy, unusual and reversible cause of left ventricular dysfunction: report of 9 cases].Ann Cardiol Angeiol (Paris). 2000 Aug;49(5):301-8. Ann Cardiol Angeiol (Paris). 2000. PMID: 12555514 Review. French.
Cited by
-
Lenient rate control versus strict rate control for atrial fibrillation: a protocol for the Danish Atrial Fibrillation (DanAF) randomised clinical trial.BMJ Open. 2021 Mar 31;11(3):e044744. doi: 10.1136/bmjopen-2020-044744. BMJ Open. 2021. PMID: 33789853 Free PMC article.
-
Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias.Clin Pharmacokinet. 2016 Aug;55(8):991-1002. doi: 10.1007/s40262-016-0372-9. Clin Pharmacokinet. 2016. PMID: 26946135
-
Usefulness of the WCD in patients with suspected tachymyopathy.Clin Res Cardiol. 2018 Jan;107(1):70-75. doi: 10.1007/s00392-017-1159-1. Epub 2017 Oct 9. Clin Res Cardiol. 2018. PMID: 28993851
-
Prevention of New-Onset Heart Failure in Atrial Fibrillation: The Role of Pharmacological Management.Am J Cardiovasc Drugs. 2025 Mar;25(2):147-155. doi: 10.1007/s40256-024-00703-y. Epub 2024 Nov 24. Am J Cardiovasc Drugs. 2025. PMID: 39581937 Review.
-
Heart failure and atrial flutter: a systematic review of current knowledge and practices.ESC Heart Fail. 2021 Dec;8(6):4484-4496. doi: 10.1002/ehf2.13526. Epub 2021 Sep 10. ESC Heart Fail. 2021. PMID: 34505352 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical